# A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies

> **NCT04008524** · — · AVAILABLE · sponsor: **Institute of Hematology & Blood Diseases Hospital, China**

## Conditions studied

- Relapsed and Refractory Hematological Malignancies

## Interventions

- **BIOLOGICAL:** CAR-T cells

## Key facts

- **NCT ID:** NCT04008524
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04008524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04008524, "A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04008524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*